Antisense Therapeutics Presentation - NWR Virtual Small Cap Investor Conference, Series 2

preview_player
Показать описание
Presenter: Mark Diamond (CEO & Managing Director)

Antisense is a drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Рекомендации по теме